Hanbetai Injection

Hanbetai Injection is a biosimilar to bevacizumab. It is indicated for the treatment of patients with metastatic colorectal cancer and advanced, metastatic or recurrent non-small cell lung cancer.


File format
PDF
Published
30 October, 2023
Updated
30 October, 2023
MD5 checksum
66620ECA8A577EA0A1FF3234225767C7
Download PDF

Also Manuals